SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Pharmos (PARS)
PARS 2.700+13.6%Jan 21 4:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Zvi Steinberg who wrote (703)4/11/1999 11:51:00 AM
From: David Israel-Rosen  Read Replies (1) of 1386
 
The\Story is as follows:

0) I WOULD LIKE TO INFORM THE TREAD BUT KEEP SENSITYIVE INFORMATION PRIVATE. I MUST TELL YOU THAT I AM VERY CONFIDENT WITH SUMMER COMPLETION AND ADDITIONAL SUPRISES IN THE TIME BETWEEN NOW AND THAN :

1) 5 MAJOR companies are completing the review of the HU211 data and answers to questions they asked PARS

2) in early May negotiations will be started for 3 indications: HEART. HEAD TRAUMA, STROKE

3) the most likely deal is going to be in the 50-100MM with significant %upfront. 15% royalties + co-marketing rights

BEST REGARDS

DAVID
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News